Improved TLR3 agonist compositions

Details for Australian Patent Application No. 2009239655 (hide)

Owner Innate Pharma

Inventors Paturel, Carine; Morel, Yannis; Belmant, Christian; Gauthier, Laurent; Aubin, Eric; Bregeon, Delphine

Agent Davies Collison Cave

Pub. Number AU-A-2009239655

PCT Pub. Number WO2009/130616

Priority 61/154,229 20.02.09 US; 61/047,969 25.04.08 US

Filing date 22 April 2009

Wipo publication date 29 October 2009

International Classifications

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

16 December 2010 PCT application entered the National Phase

  PCT publication WO2009/130616 Priority application(s): WO2009/130616

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009239658-Duodenal liner device

2009239651-Prion epitopes and methods of use thereof